Anaphylaxis in America: A national physician survey - 05/03/15
![](/templates/common/images/mail.png)
The Asthma and Allergy Foundation of America supported this study. |
|
Disclosure of potential conflict of interest: A. M. Altman has received research support from the National Institutes of Health (NIH) and is employed by the Johns Hopkins University School of Medicine. C. A. Camargo has received consultancy fees from the Asthma and Allergy Foundation of America, Dey/Mylan, and Sanofi-Aventis and has received research support from Sanofi-Aventis. F. E. R. Simons is a board member for the Sanofi Canada Medical Advisory Board. P. Lieberman has received research support from Meda, Sanofi, Mylan, AstraZeneca, Genentech, and Novartis. H. A. Sampson has received research support from the National Institute of Allergy and Infectious Diseases/NIH and the Food Allergy Research and Education; is Chair of the PhARF Award review committee; has received consultancy fees from Allertein Therapeutics, Regeneron, and Danone Research Institute; and has received lecture fees from ThermoFisher Scientific, UCB, and Pfizer. L. B. Schwartz has received consultancy fees from Sanofi, Viropharma, and Genentech; has received research support from GlaxoSmithKline, NeilMed, Merck, CSL Behring, and Dyax; and has received royalties from ThermoFisher, Hycult & BioLegend, Millipore & Santa Cruz, Elsevier, and UpToDate. F. M. Zitt has received lecture fees from Integrity/Mylan and Sanofi and has received payment for the development of educational presentations from Integrity. C. Collins has received research support from Sanofi-Aventis and Pfizer and has received travel support from Mylan Specialty, LLP. M. Tringale has received research support from Sanofi-Aventis. R. A. Wood has received consultancy fees from the Asthma and Allergy Foundation of America, is employed by Johns Hopkins University, has received research support from the NIH, and has received royalties from UpToDate. M. Wilkinson declares that she has no relevant conflicts of interest. |
Vol 135 - N° 3
P. 830-833 - mars 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?